$26.59

(%)
Live
Previous Close

$26.59

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$150.1 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

New York Stock Exchange

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines acco...


Community
  • 0 posts discussing
1

Watchers

4

Visitors


Recent News

Pfizer (NYSE:PFE) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 3 3 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 1 0 0 3M Ago 2 0 2 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $37.33, along with a high estimate of $45.00 and a low estimate of $27.00. This current average reflects an increase of 1.8% from the previous average price target of $36.67. Understanding Analyst Ratings: A Comprehensive Breakdown A clear picture of Pfizer's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Louise Chen Cantor Fitzgerald Maintains Overweight $45.00 - Vamil Divan Guggenheim Announces Buy $36.00 - Louise Chen Cantor Fitzgerald Maintains Overweight $45.00 - Louise Chen Cantor Fitzgerald Maintains Overweight $45.00 - Steve Scala TD Cowen Announces Market Perform $32.00 - Robyn Karnauskas Truist Securities Lowers Buy $36.00 $42.00 Colin Bristow UBS Lowers Neutral $27.00 $34.00 Carter Gould Barclays Lowers Equal-Weight $28.00 $34.00 Robyn Karnauskas Truist Securities Maintains Buy $42.00 - Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their ...Full story available on Benzinga.com

Related tickers: PFE.

Read Full Article

It will take a lot, but this goal isn't out of reach for these stocks.

Related tickers: VKTX, LLY, AZN, PFE, NVO, AMGN, KRYS.

Read Full Article
Trending Tickers
CELU

XNAS

$3.66
(%)
CRGE

XNAS

$0.02
(%)
MESA

XNAS

$0.95
(%)
RDHL

XNAS

$0.57
(%)
SOUN

XNAS

$0.00
(%)